GLP-1 (7-36) amide

DRUG3 trials

Sponsors

Johns Hopkins University, Papworth Hospital NHS Foundation Trust, University of Copenhagen

Conditions

Angina PectorisCABGEmesis

Phase 1

Cardioprotective Effects of GLP-1 and Their Mechanisms

CompletedNCT02128022

Papworth Hospital NHS Foundation TrustAngina Pectoris

Start: 2014-07-31End: 2016-03-31Updated: 2016-04-11

Phase 2

Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) Surgery

TerminatedNCT00966654

Johns Hopkins UniversityCABG

Start: 2008-09-30End: 2012-09-30Updated: 2017-07-12

Unknown Phase

The Antiemetic Effects of Increased Splanchnic Perfusion, Induced by the Gut Hormone GIP, in Healthy Individuals

Enrolling by invitationNCT07687589

University of CopenhagenEmesis

Start: 2026-05-19End: 2027-04-28Target: 14Updated: 2026-07-07

Related Papers

Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies.

2016-07-1914 citations